How to use
Apply once or twice a day to clean, dry skin.
R431.00
BIRETIX Duo Anti-Blemish Gel
Face gel. Prevents and corrects spots.
Facial gel that reduces and improves the first signs of blemishes in acne-prone skin. Its formula incorporates exclusive RetinSphere® Technology and its innovative BIOPEP 15 active ingredient that reduces the proliferation of microorganisms combined with vitamin E, which helps maintain equilibrium of the skin barrier. It helps to control oil production, improves skin texture and corrects imperfections with excellent tolerance, suitable for use in summer and even on the most sensitive skin. Tested under dermatological control.
Size: 30 ml
Apply once or twice a day to clean, dry skin.
Anti-blemish
Removes excess oil, without drying the skin
Maintains skin equilibrium
Excellent tolerance
Tested under dermatological control
RetinSphere® Technology, New-generation Retinoid: Innovative technology that combines two high tolerance retinoids that stimulate epidermal renewal. It smooths skin and reduces blemishes and imperfections.
BIOPEP-15: Plant-based peptide technology that contrasts proliferation of Cutibacterium acnes, the main bacteria involved in the development of acne.
RetinSphere® Technology (hydroxypinacolone retinoate and retinol glycospheres), BIOPEP 15, Salicylic acid, Vitamin E.
Aqua, Glycerin, Butylene Glycol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Polysorbate 80, Dimethyl Isosorbide, Benzyl Alcohol, Isohexadecane, Hydrogenated Lecithin, Trehalose, Salicylic Acid, Tocopherol, Hydroxypinacolone Retinoate, Phenoxyethanol, Lecithin, Dehydroacetic Acid, Palmitoyl Hydroxypropyltrimonium Amylopectin/Glycerin Crosspolymer, Oryza Sativa Bran Extract, Polysorbate 20, Honey Extract, Retinol, Ascorbyl Palmitate, Beta-Sitosterol, Squalane, Glycine Soja Oil, Sodium Hydroxide, Oligopeptide-10.
You must be logged in to post a review.
Main Centres: Johannesburg, Cape Town, Pretoria.
Remember that weekends and public holidays are not work days.
Reviews
There are no reviews yet.